VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
RVPRetractable Technologies, Inc.
$0.67$20M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

RVP logoRetractable Technologies, Inc.(RVP)Earnings, Financials & Key Ratios

RVP•AMEX
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDrug delivery and infusion consumables
AboutRetractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Show more
  • Revenue$38M+15.8%
  • EBITDA-$12M+8.0%
  • Net Income-$13M-5.7%
  • EPS (Diluted)-0.43-7.5%
  • Gross Margin0.12%+104.0%
  • EBITDA Margin-32.55%+20.5%
  • Operating Margin-52.84%+17.3%
  • Net Margin-32.84%+8.7%
  • ROE-15.56%-22.0%

RVP Key Insights

Retractable Technologies, Inc. (RVP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Trading at only 0.3x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Sales declining 14.1% over 5 years
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when RVP posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

RVP Price & Volume

Retractable Technologies, Inc. (RVP) stock price & volume — 10-year historical chart

Loading chart...

RVP Growth Metrics

Retractable Technologies, Inc. (RVP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.62%
5 Years-14.11%
3 Years-26.1%
TTM10.08%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM72.43%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM72.27%

Return on Capital

10 Years4.67%
5 Years4.6%
3 Years-11.17%
Last Year-14.19%

RVP Recent Earnings

Retractable Technologies, Inc. (RVP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 15, 2026
Metric
Actual
Est
EPS
$0.14
—
Rev
$7M
—
Q2 2026
Mar 27, 2026
Metric
Actual
Est
EPS
$0.08
—
Rev
$9M
—
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.01
—
Rev
$10M
—
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.12
—
Rev
$10M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 15, 2026
$0.14
$7M
Q2 2026Mar 27, 2026
$0.08
$9M
Q4 2025Nov 14, 2025
$0.01
$10M
Q3 2025Aug 14, 2025
$0.12
$10M
Based on last 12 quarters of dataView full earnings history →

RVP Peer Comparison

Retractable Technologies, Inc. (RVP) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NNBR logoNNBRNN, Inc.Direct Competitor147.24M2.79-2.61-9.06%-8.03%-22.93%1.44
MMSI logoMMSIMerit Medical Systems, Inc.Direct Competitor4.01B67.2231.5611.66%9.03%8.95%0.57
UTMD logoUTMDUtah Medical Products, Inc.Direct Competitor214.77M67.0419.26-5.83%29.3%9.56%0.00
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
PNTG logoPNTGThe Pennant Group, Inc.Direct Competitor1.16B33.4439.8136.31%2.96%8.42%1.21
BDX logoBDXBecton, Dickinson and CompanyProduct Competitor52.16B143.9824.708.23%5.33%4.54%0.76
SNN logoSNNSmith & Nephew plcProduct Competitor12.77B30.0820.896.34%6.88%15.06%0.63
HSIC logoHSICHenry Schein, Inc.Product Competitor9.17B79.9224.444.03%3.02%8.24%0.77

Compare RVP vs Peers

Retractable Technologies, Inc. (RVP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NNBR

Most directly comparable listed peer for RVP.

Scale Benchmark

vs MCK

Larger-name benchmark to compare RVP against a more recognizable public peer.

Peer Set

Compare Top 5

vs NNBR, MMSI, UTMD, NVCR

RVP Income Statement

Retractable Technologies, Inc. (RVP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
34.49M33.27M41.8M81.86M188.38M94.82M43.6M33.05M38.27M37.15M
Revenue Growth %
15.65%-3.53%25.61%95.86%130.12%-49.67%-54.02%-24.19%15.78%10.08%
Cost of Goods Sold
24.52M23.05M27.66M44.85M93.03M66.57M34.49M34.08M38.22M37.07M
COGS % of Revenue
71.09%69.28%66.17%54.79%49.38%70.2%79.11%103.11%99.88%-
Gross Profit
9.97M▲ 0%
10.22M▲ 2.5%
14.14M▲ 38.3%
37.01M▲ 161.8%
95.35M▲ 157.7%
28.25M▼ 70.4%
9.11M▼ 67.8%
-1.03M▼ 111.3%
47.05K▲ 104.6%
73.59K▲ 0%
Gross Margin %
28.91%30.72%33.83%45.21%50.62%29.8%20.89%-3.11%0.12%0.2%
Gross Profit Growth %
-3.58%2.51%38.31%161.77%157.65%-70.37%-67.76%-111.29%104.58%-
Operating Expenses
13.75M11.8M11.17M12.94M22.76M29.11M20.6M20.08M20.27M22.74M
OpEx % of Revenue
39.86%35.47%26.71%15.8%12.08%30.7%47.24%60.75%52.97%-
Selling, General & Admin
13.01M11.18M10.65M12.36M21.86M28.58M20.01M19.4M19.59M20.27M
SG&A % of Revenue
37.72%33.6%25.48%15.1%11.6%30.14%45.91%58.71%51.2%-
Research & Development
740.57K621.37K516.1K574.53K901.38K525.73K581.17K673.94K675.57K654.79K
R&D % of Revenue
2.15%1.87%1.23%0.7%0.48%0.55%1.33%2.04%1.77%-
Other Operating Expenses
0000000001.82M
Operating Income
-3.78M▲ 0%
-1.32M▲ 65.1%
2.97M▲ 325.1%
24.07M▲ 710.0%
72.6M▲ 201.6%
-852.98K▼ 101.2%
-11.49M▼ 1246.8%
-21.11M▼ 83.7%
-20.22M▲ 4.2%
-22.67M▲ 0%
Operating Margin %
-10.95%-3.97%7.11%29.4%38.54%-0.9%-26.35%-63.86%-52.84%-61.02%
Operating Income Growth %
-7.74%65.06%325.11%709.96%201.59%-101.17%-1246.84%-83.71%4.19%-
EBITDA
-2.94M-433.38K3.82M24.9M73.85M3.75M-3.96M-13.54M-12.45M-14.88M
EBITDA Margin %
-8.53%-1.3%9.15%30.42%39.2%3.95%-9.09%-40.96%-32.55%-40.05%
EBITDA Growth %
-11.75%85.28%982.35%551.24%196.56%-94.92%-205.63%-241.72%7.98%2.33%
D&A (Non-Cash Add-back)
834.95K886.81K852.08K832.07K1.26M4.6M7.53M7.57M7.77M7.79M
EBIT
-3.71M-1.18M3.32M26.33M75.18M5.33M-8.76M-3.4M-20.22M-8.16M
Net Interest Income
-145.07K-23.73K184.27K132.48K39.28K-160.7K1.29M877.93K459.46K598.65K
Interest Income
65.69K153.46K351.17K392.75K266.47K9.95K1.45M1M547.36K683.54K
Interest Expense
210.76K177.19K166.9K260.26K227.18K170.65K152.17K122.5K87.9K84.89K
Other Income/Expense
-145.07K236.78K184.27K2M2.36M6.02M2.57M17.59M7.95M16.38M
Pretax Income
-3.92M▲ 0%
-1.35M▲ 65.5%
3.16M▲ 333.2%
26.07M▲ 726.1%
74.95M▲ 187.5%
5.16M▼ 93.1%
-8.92M▼ 272.7%
-3.52M▲ 60.5%
-12.27M▼ 248.7%
-6.28M▲ 0%
Pretax Margin %
-11.37%-4.07%7.55%31.85%39.79%5.44%-20.45%-10.65%-32.08%-16.91%
Income Tax
-187.61K-13.32K7.88K1.85M18.89M83.87K-1.91M8.37M291.29K7.37K
Effective Tax Rate %
4.78%0.98%0.25%7.1%25.2%1.62%21.37%-237.65%-2.37%-0.12%
Net Income
-3.74M▲ 0%
-1.34M▲ 64.1%
3.15M▲ 335.0%
24.22M▲ 669.4%
56.06M▲ 131.5%
5.08M▼ 90.9%
-7.01M▼ 238.1%
-11.89M▼ 69.5%
-12.57M▼ 5.7%
-6.29M▲ 0%
Net Margin %
-10.83%-4.03%7.53%29.59%29.76%5.36%-16.08%-35.97%-32.84%-16.93%
Net Income Growth %
-1.11%64.13%334.95%669.42%131.45%-90.94%-238.05%-69.54%-5.71%72.43%
Net Income (Continuing)
-3.74M-1.34M3.15M24.22M56.06M5.08M-7.01M-11.89M-12.57M-6.29M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.12▲ 0%
-0.04▲ 65.8%
0.07▲ 282.4%
0.80▲ 969.5%
1.63▲ 103.7%
0.15▼ 90.8%
-0.24▼ 260.0%
-0.40▼ 66.7%
-0.43▼ 7.5%
-0.21▲ 0%
EPS Growth %
7.69%65.83%282.44%969.52%103.75%-90.8%-260%-66.67%-7.5%72.27%
EPS (Basic)
-0.12-0.040.070.801.650.15-0.24-0.40-0.43-
Diluted Shares Outstanding
31.96M32.67M32.67M33.3M34.24M32.96M29.94M29.94M29.94M29.94M
Basic Shares Outstanding
31.72M32.67M32.67M33.17M33.87M32.9M29.94M29.94M29.94M29.94M
Dividend Payout Ratio
----------

RVP Balance Sheet

Retractable Technologies, Inc. (RVP) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
26.61M23.85M28.41M69.48M104.51M88.81M77.65M73.27M63.08M59.96M
Cash & Short-Term Investments
14.88M10.64M13.71M25.65M42.43M49.38M47.29M44.56M36.97M35.62M
Cash Only
14.88M9.65M5.93M17.57M29.16M19.72M12.67M4.24M2.59M2.77M
Short-Term Investments
0996.23K7.77M8.08M13.27M29.66M34.62M40.33M34.38M32.85M
Accounts Receivable
5.11M5.01M6.61M32.91M40.78M17.48M11.83M8.77M8.21M7.29M
Days Sales Outstanding
54.0254.9957.76146.7479.0267.2999.0296.8178.3381.91
Inventory
6.21M7.55M7.45M10.23M20.59M20.68M17.58M19.19M17.19M16.43M
Days Inventory Outstanding
92.38119.4698.3283.2880.78113.42186.06205.54164.15183.26
Other Current Assets
418.15K644.8K635.2K684.32K701.97K1.26M952.67K753.06K711.27K622.43K
Total Non-Current Assets
11.55M12.95M17.43M35.49M108.65M121.93M102.02M87.45M79.55M77.64M
Property, Plant & Equipment
11.35M10.85M10.71M30.82M87.93M100.15M93.48M87.35M79.18M77.31M
Fixed Asset Turnover
3.04x3.07x3.90x2.66x2.14x0.95x0.47x0.38x0.48x0.46x
Goodwill
0000000000
Intangible Assets
0000000000
Long-Term Investments
01.99M50.39K0000000
Other Non-Current Assets
194.51K103.68K5.96K44.57K5.67K184.52K152.06K103.63K366.91K330.94K
Total Assets
38.16M▲ 0%
36.79M▼ 3.6%
45.84M▲ 24.6%
104.97M▲ 129.0%
213.15M▲ 103.1%
210.74M▼ 1.1%
179.67M▼ 14.7%
160.72M▼ 10.5%
142.63M▼ 11.3%
137.6M▲ 0%
Asset Turnover
0.90x0.90x0.91x0.78x0.88x0.45x0.24x0.21x0.27x0.26x
Asset Growth %
-1.61%-3.57%24.58%129.02%103.06%-1.13%-14.74%-10.55%-11.26%-34.8%
Total Current Liabilities
7.9M8.54M8.26M27.9M35.32M12.14M9.38M8.78M9.6M10.45M
Accounts Payable
4.96M5.37M5.01M16.26M20.4M6.4M4.78M4.29M5.34M5.38M
Days Payables Outstanding
73.7985.0266.08132.2980.0635.1250.5845.965147.65
Short-Term Debt
410.95K406.36K343.3K1.03M1.39M1.38M303.99K332.48K365.28K481.93K
Deferred Revenue (Current)
355.74K860.93K998.6K1.69M2.34M435.92K201.49K376.56K352.64K2.37M
Other Current Liabilities
1.62M540.85K1.28M826.76K5.18M2.85M865.11K1.07M762.21K3.26M
Current Ratio
3.37x2.79x3.44x2.49x2.96x7.32x8.28x8.34x6.57x5.74x
Quick Ratio
2.58x1.91x2.54x2.12x2.38x5.61x6.41x6.16x4.78x4.17x
Cash Conversion Cycle
72.6189.449097.7479.75145.59234.5256.39191.49217.53
Total Non-Current Liabilities
3.08M2.64M9.04M27.19M78.66M92.07M71.01M64.77M58.66M57.06M
Long-Term Debt
3.08M2.64M2.38M2.71M2.85M1.53M1.23M900.04K530.37K434.12K
Capital Lease Obligations
0000000000
Deferred Tax Liabilities
07.43M6.66M2.19M6.85M15.08M0000
Other Non-Current Liabilities
082.36K024.48M68.96M75.46M69.77M63.87M58.13M56.62M
Total Liabilities
10.98M11.18M17.29M55.09M113.98M104.21M80.38M73.55M68.26M67.5M
Total Debt
3.49M3.05M2.72M3.74M4.24M2.92M1.54M1.23M895.64K916.05K
Net Debt
-11.39M-6.6M-3.21M-13.83M-24.92M-16.8M-11.13M-3M-1.69M-1.85M
Debt / Equity
0.13x0.12x0.10x0.08x0.04x0.03x0.02x0.01x0.01x0.01x
Debt / EBITDA
--0.71x0.15x0.06x0.78x----0.06x
Net Debt / EBITDA
---0.84x-0.56x-0.34x-4.48x---0.12x
Interest Coverage
-17.62x-6.64x19.91x101.18x330.91x31.25x-57.60x-27.74x-230.03x-96.15x
Total Equity
27.17M▲ 0%
25.61M▼ 5.7%
28.54M▲ 11.4%
49.88M▲ 74.8%
99.17M▲ 98.8%
106.54M▲ 7.4%
99.29M▼ 6.8%
87.17M▼ 12.2%
74.38M▼ 14.7%
70.09M▲ 0%
Equity Growth %
-3.32%-5.74%11.43%74.76%98.82%7.43%-6.8%-12.2%-14.68%-41.69%
Book Value per Share
0.850.780.871.502.903.233.322.912.482.34
Total Shareholders' Equity
27.17M25.61M28.54M49.88M99.17M106.54M99.29M87.17M74.38M70.09M
Common Stock
0000000000
Retained Earnings
-35.7M-37.04M-33.89M-9.67M41.18M46.03M38.79M26.67M13.87M9.59M
Treasury Stock
0000-5.27M-12.89M-12.89M-12.89M-12.89M-12.89M
Accumulated OCI
-23.78M-24.67M00000000
Minority Interest
0000000000

RVP Cash Flow Statement

Retractable Technologies, Inc. (RVP) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-2.92M-1.2M2.19M19M32.79M16.77M2.77M-11.56M-7.06M-6.96M
Operating CF Margin %
-8.47%-3.59%5.25%23.21%17.41%17.68%6.35%-34.97%-18.46%-
Operating CF Growth %
-267.67%59.1%283.58%765.61%72.62%-48.87%-83.5%-517.7%38.87%93.12%
Net Income
-3.74M-1.34M3.15M27.2M56.06M5.08M-7.01M-11.89M-12.57M-6.29M
Depreciation & Amortization
834.95K886.81K852.08K832.07K1.26M4.6M7.53M7.57M7.77M7.79M
Stock-Based Compensation
672.22K000010.13M0000
Deferred Taxes
000-4.63M-9.23M7.35M-1.87M8.39M0-288
Other Non-Cash Items
24.27K-249.94K-137.24K-4.92M2.03M-5.47M-467.04K-16.14M-3.06M-9.54M
Working Capital Changes
-718.04K-492.43K-1.67M513.18K-17.32M-4.92M4.59M504.16K790.82K1.08M
Change in Receivables
-2.05M132.14K-1.55M-14.53M-13.88M19.08M3M2.49M219.59K-1.57M
Change in Inventory
811.06K-1.04M94.5K-2.78M-10.36M-94.25K2.93M-1.61M-197.47K1.69M
Change in Payables
485.99K411.93K-362.07K11.25M4.15M-14M-1.63M-488.45K1.05M660.27K
Cash from Investing
-91.88K-3.37M-5.28M-19.33M-63.04M-31.2M-10.76M3.66M5.98M6.91M
Capital Expenditures
-91.88K-382.16K-632.08K-21.05M-58.37M-16.83M-852.98K-1.44M-535.64K-454.84K
CapEx % of Revenue
0.27%1.15%1.51%25.71%30.98%17.75%1.96%4.36%1.4%1.22%
Acquisitions
0000000000
Investments
----------
Other Investing
00000000-16.29K-41.08K
Cash from Financing
1.69M-666.8K-626.84K11.96M41.84M4.99M941.64K-535.43K-567.32K-574.62K
Debt Issued (Net)
-436.28K-446.35K-407.01K1.1M-274.79K-283.93K-281.87K-304.99K-336.88K-344.17K
Equity Issued (Net)
2.35M00439.84K-6.42M-8.71M-1.11M000
Dividends Paid
-220.45K-220.45K-219.82K-216.64K-3.82M-252.88K-232.44K-230.44K-230.44K-230.44K
Share Repurchases
000-482.67K-6.47M-8.72M-1.11M000
Other Financing
00010.64M52.37M14.24M2.56M000
Net Change in Cash
-1.32M▲ 0%
-5.23M▼ 295.9%
-3.71M▲ 29.0%
11.63M▲ 413.3%
11.6M▼ 0.3%
-9.44M▼ 181.4%
-7.05M▲ 25.3%
-8.43M▼ 19.5%
-1.65M▲ 80.5%
-617.02K▲ 0%
Free Cash Flow
-3.01M▲ 0%
-1.58M▲ 47.7%
1.56M▲ 199.0%
-2.05M▼ 231.4%
-25.57M▼ 1145.9%
-61.95K▲ 99.8%
1.91M▲ 3189.4%
-13M▼ 779.1%
-7.6M▲ 41.5%
-7.41M▲ 0%
FCF Margin %
-8.74%-4.74%3.74%-2.51%-13.58%-0.07%4.39%-39.33%-19.86%-19.95%
FCF Growth %
-9.94%47.66%199.04%-231.36%-1145.87%99.76%3189.38%-779.09%41.52%39.79%
FCF per Share
-0.09-0.050.05-0.06-0.75-0.000.06-0.43-0.25-0.25
FCF Conversion (FCF/Net Income)
0.78x0.89x0.70x0.78x0.58x3.30x-0.39x0.97x0.56x1.18x
Interest Paid
210.76K177.19K0260.26K118.16K110.54K000-15.62K
Taxes Paid
1.03K1.17K02.11M27.12M12.32M0000

RVP Key Ratios

Retractable Technologies, Inc. (RVP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-13.52%-5.08%11.63%61.78%75.23%4.94%-6.81%-12.75%-15.56%-8.45%
Return on Invested Capital (ROIC)
-17.92%-5.69%10.05%58.82%98.72%-0.78%-9.69%-18.37%-19.34%-23.47%
Gross Margin
28.91%30.72%33.83%45.21%50.62%29.8%20.89%-3.11%0.12%0.2%
Net Margin
-10.83%-4.03%7.53%29.59%29.76%5.36%-16.08%-35.97%-32.84%-16.93%
Debt / Equity
0.13x0.12x0.10x0.08x0.04x0.03x0.02x0.01x0.01x0.01x
Interest Coverage
-17.62x-6.64x19.91x101.18x330.91x31.25x-57.60x-27.74x-230.03x-96.15x
FCF Conversion
0.78x0.89x0.70x0.78x0.58x3.30x-0.39x0.97x0.56x1.18x
Revenue Growth
15.65%-3.53%25.61%95.86%130.12%-49.67%-54.02%-24.19%15.78%10.08%
Related:RVP Dividend History·RVP Revenue History·RVP Price History·RVP P/E History·RVP Financial Ratios·RVP Institutional Holders

RVP SEC Filings & Documents

Retractable Technologies, Inc. (RVP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 13, 2026·SEC

Material company update

Apr 10, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 27, 2026·SEC

FY 2025

Mar 28, 2025·SEC

FY 2024

Mar 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 15, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 14, 2025·SEC

RVP Frequently Asked Questions

Retractable Technologies, Inc. (RVP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Retractable Technologies, Inc. (RVP) reported $37.1M in revenue for fiscal year 2025. This represents a 285% increase from $9.6M in 2000.

Retractable Technologies, Inc. (RVP) grew revenue by 15.8% over the past year. This is strong growth.

Retractable Technologies, Inc. (RVP) reported a net loss of $6.3M for fiscal year 2025.

Dividend & Returns

Yes, Retractable Technologies, Inc. (RVP) pays a dividend with a yield of 1.15%. This makes it attractive for income-focused investors.

Retractable Technologies, Inc. (RVP) has a return on equity (ROE) of -15.6%. Negative ROE indicates the company is unprofitable.

Retractable Technologies, Inc. (RVP) had negative free cash flow of $7.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in RVP back in 2000?

Total return calculator · dividends reinvested · 26+ years of data

See returns →

How much would $100/month in RVP be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →